{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T11:37:30Z","timestamp":1724499450263},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.clinthera.2016.11.019","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T22:56:18Z","timestamp":1481842578000},"page":"130-137","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Determinants of Treatment Eligibility in Veterans With Hepatitis C Viral Infection"],"prefix":"10.1016","volume":"39","author":[{"given":"Janice","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Carr-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Malmstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Maniar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C. Del","family":"Re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jannet M.","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2016.11.019_bib1","unstructured":"Centers for Disease Control and Prevention. Disease burden from viral hepatitis A, B, and C, in the United States. 2013. http:\/\/www.cdc.gov\/hepatitis\/HCV\/StatisticsHCV.htm. Accessed September 1, 2015."},{"key":"10.1016\/j.clinthera.2016.11.019_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/epirev\/mxu002","article-title":"Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs","volume":"37","author":"Beste","year":"2015","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.clinthera.2016.11.019_bib3","unstructured":"U.S. Department of Veterans Affairs. State of Care for Veterans with Hepatitis C 2014. http:\/\/www.cdc.gov\/hepatitis\/HCV\/StatisticsHCV.htm. Accessed September 1, 2015."},{"key":"10.1016\/j.clinthera.2016.11.019_bib4","unstructured":"United States Department of Veterans Affairs. HCV registry Veterans in VHA care in 2014, for the nation, by VISN and by station, May 2015. http:\/\/vaww.hepatitis.va.gov\/data-reports\/ccr2014\/Demo-HCV3PopInCare-Jan15-HCV-2014-All.asp. Accessed September 1, 2015."},{"key":"10.1016\/j.clinthera.2016.11.019_bib5","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.3748\/wjg.v20.i32.11033","article-title":"Chronic hepatitis C and liver fibrosis","volume":"20","author":"Sebastiani","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinthera.2016.11.019_bib6","unstructured":"World Health Organization. Hepatitis C key facts. July 2015. http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/. Accessed September 1, 2015."},{"key":"10.1016\/j.clinthera.2016.11.019_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamainternmed.2015.6011","article-title":"Cost-effectiveness of early treatment of hepatitis c virus genotype 1 by stage of liver fibrosis in a US treatment-na\u00efve population","volume":"176","author":"Chahal","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.clinthera.2016.11.019_bib8","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/cncr.29855","article-title":"Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis","volume":"122","author":"Tapper","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2016.11.019_bib9","unstructured":"United States Department of Veterans Affairs. HCV viremic Veterans in VHA care in 2014 with first or ever VHA diagnosis of cirrhosis\/ALD by ICD-9 in the year for the Nation, by VISN and by station. http:\/\/vaww.hepatitis.va.gov\/data-reports\/ccr2014\/Cond-DxGrpFirstEverInCare-Jan15-HCVVir-CCRALD-2014-All.asp. Accessed September 1, 2015."},{"key":"10.1016\/j.clinthera.2016.11.019_bib10","unstructured":"AASLD\/IDSA\/IAS\u2013USA. Recommendations for testing, managing, and treating hepatitis C. http:\/\/www.hcvguidelines.org. Accessed September 1, 2015."},{"key":"10.1016\/j.clinthera.2016.11.019_bib11","unstructured":"United States Department of Veterans Affairs. Chronic hepatitis C virus (HCV) infection: treatment considerations from the Department of Veterans Affairs national hepatitis C resource center program and the Office of Public Health. http:\/\/vaww.hepatitis.va.gov\/pdf\/treatment-considerations-2015-07.pdf. Accessed on September 1, 2015."},{"issue":"7","key":"10.1016\/j.clinthera.2016.11.019_bib12","doi-asserted-by":"crossref","first-page":"e0132056","DOI":"10.1371\/journal.pone.0132056","article-title":"Correlates of initiation of treatment for chronic hepatitis C infection in United States Veterans, 2004-2009","volume":"10","author":"Gundlapalli","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinthera.2016.11.019_bib13","unstructured":"AASLD-IDSA. Recommendations for testing, managing, and treating hepatitis C.\u00a0http:\/\/www.hcvguidelines.org. Accessed on August 1, 2016."},{"issue":"7","key":"10.1016\/j.clinthera.2016.11.019_bib14","doi-asserted-by":"crossref","first-page":"e102883","DOI":"10.1371\/journal.pone.0102883","article-title":"The hepatitis C cascade of care among HIV infected patients: A call to address ongoing barriers to care","volume":"9","author":"Cachay","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinthera.2016.11.019_bib15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jval.2016.01.010","article-title":"Economic and public health impacts of policies restricting access to hepatitis C treatment for medicaid patients","volume":"19","author":"Chidi","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.clinthera.2016.11.019_bib16","unstructured":"United States Department of Veterans Affairs. Chronic hepatitis C virus (HCV) infection: Treatment considerations from the Department of Veterans Affairs national hepatitis C resource center program and the Office of Patient Care Services. http:\/\/www.hepatitis.va.gov\/provider\/guidelines\/hcv-treatment-considerations.pdf. Accessed on August 1, 2016."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816308578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816308578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:29:54Z","timestamp":1536193794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291816308578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0149291816308578"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.11.019","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of Treatment Eligibility in Veterans With Hepatitis C Viral Infection","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}